Augustine Therapeutics is proud to announce as one of the Sponsors and Participants of the 2022 Global CMT Research Convention

The event gathers both patients and researchers from academia and the pharma industry to discuss widely innovative therapeutic solutions for Charcot-Marie-Tooth disease. This yearly convention enhances the scope and possibilities of research discoveries a step forward for the people who are living with CMT!

On September 17th, from 2:50 pm to 3:45 pm ET (8:50 pm to 9:45 pm CET), our CEO Dr. Sylvain Celanire will be on the panelist of the "Biopharma Activity in CMT" session. There will be a key discussion on why CMT is the next indication of interest for companies and investors.

We feel extremely thankful to CMT Research Foundation for providing such a global platform. This boosts the awareness amongst every individual who is going through CMT, and it helps us to work with that objective. | soon production